RBM20相关扩张型心肌病中核糖核蛋白颗粒失调损害线粒体功能
该研究探讨RBM20功能获得性(GoF)与功能缺失性(LoF)变异对心脏的影响,利用小鼠模型及人诱导多能干细胞衍生心脏类器官,发现GoF变异导致线粒体蛋白可溶性下降、氧化磷酸化受损和钙处理异常,而LoF变异无此表现,提示胞质错位而非剪接缺陷驱动线粒体功能障碍。
要点
- RBM20 GoF变异通过胞质错位下调线粒体蛋白(如TMEM65)并损害氧化磷酸化。
- GoF变异导致线粒体膜蛋白可溶性降低、线粒体增大和嵴结构紊乱。
- 该机制可解释GoF变异患者心衰表型更严重,且人心脏类器官验证了变异特异性。
核心结论
- RBM20胞质错位通过降低线粒体蛋白丰度破坏线粒体功能,导致氧化磷酸化失败和线粒体钙处理异常。
研究设计与样本
- 研究使用小鼠模型进行蛋白质组学分析、蛋白溶解度测定、线粒体呼吸和钙流分析及超微结构成像。
- 研究使用人诱导多能干细胞衍生心脏类器官验证变异特异性表型。
主要发现
- Rbm20 GoF而非LoF变异引起可溶性线粒体蛋白转录后下调,包括钙外排调节因子TMEM65。
- GoF变异导致线粒体膜蛋白溶解度降低,电镜显示线粒体增大和嵴结构紊乱。
- 功能实验证实GoF模型氧化磷酸化受损、线粒体膜电位降低和钙处理异常。
- 人心脏类器官重现上述发现,表明胞质错位而非剪接缺陷驱动线粒体功能障碍。
临床怎么用
- RBM20 GoF变异患者可能需更积极监测心衰并考虑靶向线粒体功能的治疗策略。
- 线粒体mRNA/蛋白调控成为心脏能量学关键节点,为RBM20相关心肌病提供机制见解。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pathogenic variants in RBM20 cause severe dilated cardiomyopathy. Loss-of-function variants disrupt splicing; neomorphic gain-of-function (GoF) variants also mislocalize RBM20 to cytoplasmic ribonucleoprotein granules and are associated with more aggressive disease. The mechanism by which RBM20 mislocalization drives cardiac dysfunction remains unknown. METHODS: We investigated the effects of Rbm20 GoF and loss-of-function (LoF) variants using proteomic profiling, protein solubility assays, mitochondrial respiration and calcium flux analyses, and ultrastructural imaging in mouse models. Human induced pluripotent stem cell-derived cardioids were used to validate variant-specific phenotypes. RESULTS: Rbm20 GoF, but not LoF, variants caused posttranscriptional downregulation of soluble mitochondrial proteins, including the calcium efflux regulator TMEM65 (transmembrane protein 65), and reduced solubility of mitochondrial membrane proteins. Electron microscopy revealed enlarged mitochondria with cristae disorganization. Functional assays confirmed impaired oxidative phosphorylation, reduced mitochondrial membrane potential, and abnormal calcium handling in Rbm20 GoF models. Human cardioids reproduced these findings, demonstrating that cytoplasmic mislocalization, rather than splicing deficiency, drives mitochondrial dysfunction. CONCLUSIONS: Cytoplasmic mislocalization of RBM20 disrupts mitochondrial function by reducing mitochondrial protein abundance, leading to oxidative phosphorylation failure and abnormal mitochondrial calcium handling. This mechanism distinguishes RBM20 GoF from LoF variants and may explain the more severe heart failure phenotype observed in patients with RBM20 GoF variants. These insights advance the mechanistic understanding of RBM20-related cardiomyopathy and identify mitochondrial mRNA/protein regulation as a key node in cardiac energetics.
引用
- Kornienko J, Müller LH, Nickel A, et al. Dysregulated Ribonucleoprotein Granules Impair Mitochondrial Function in RBM20-Related Dilated Cardiomyopathy. Circulation. 2026. PMID: 42741825. doi:10.1161/CIRCULATIONAHA.125.077061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。